Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company offers oncology-related services, including sale and installation of medical equipment and software; and management and technical support services to hospitals and radiotherapy centers. It also engages in leasing radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. Concord Healthcare Group Co., Ltd. was incorporated in 2008 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Concord Healthcare Grp Co Ltd (2453) operate in?
Concord Healthcare Grp Co Ltd belongs to the Other sector and operates in the Medical Care Facilities industry.
What is Concord Healthcare Grp Co Ltd (2453) current stock price?
As of the latest data, Concord Healthcare Grp Co Ltd stock price is HK$0.74, with a previous close of HK$0.74.
What is Concord Healthcare Grp Co Ltd (2453) current market capitalization?
Concord Healthcare Grp Co Ltd market cap is approximately 230.70 million.
What is Concord Healthcare Grp Co Ltd (2453) EBITDA?
Concord Healthcare Grp Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 40.50 million.
Does Concord Healthcare Grp Co Ltd (2453) pay dividends?
No. Concord Healthcare Grp Co Ltd does not pay a dividend.
What is Concord Healthcare Grp Co Ltd (2453) beta (volatility) score?
Concord Healthcare Grp Co Ltd has a beta of -0.557, indicating lower volatility than the overall market.
